Only 3 of 10 MPAS genes (PHLDA1, DUSP4, and EPHA2) reflect MEK/ERK pathway activity significantly and consistently across multiple experimental models and clinical tissue samples of ovarian cancer. This evidence concerns the gene MAP2K7 and ovarian carcinoma.